EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glutathione S ‐transferase omega class 1 ( GSTO1 )‐associated large extracellular vesicles are involved in tumor‐associated macrophage‐mediated cisplatin resistance in bladder cancer

Yi-Cheng Pan iD, Pei-Yi Chu, Ching-Chan Lin, Ching-Yun Hsieh, Wei-Yu Hsu, Lie-Fen Shyur, Juan-Cheng Yang, Wei-Chao Chang iD, Yang-Chang Wu iD

Molecular Oncology · 2024

DOI: 10.1002/1878-0261.13659 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, 2024. Verfasst von Yi-Cheng Pan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Ph.D. Program for Cancer Biology and Drug Discovery, China Medical University and Academia Sinica, Taichung, Taiwan. Hauptthemen laut MEDLINE: Cisplatin, Drug Resistance, Neoplasm, Extracellular Vesicles, Glutathione Transferase. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Taiwan, China Medical University, China Medical University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bladder cancer poses a significant challenge to chemotherapy due to its resistance to cisplatin, especially at advanced stages. Understanding the mechanisms behind cisplatin resistance is crucial for improving cancer therapy. The enzyme glutathione S ‐transferase omega class 1 (GSTO1) is known to be involved in cisplatin resistance in colon cancer. This study focused on its role in cisplatin resistance in bladder cancer. Our analysis of protein expression in bladder cancer cells stimulated by secretions from tumor‐associated macrophages (TAMs) showed a significant increase in GSTO1. This prompted further investigation into the role of GSTO1 in bladder cancer. We found a strong correlation between GSTO1 expression and cisplatin resistance. Mechanistically, GSTO1 triggered the release of large extracellular vesicles (EVs) that promoted cisplatin efflux, thereby reducing cisplatin–DNA adduct formation and enhancing cisplatin resistance. Inhibition of EV release effectively counteracted the cisplatin resistance associated with GSTO1. In conclusion, GSTO1‐mediated EV release may contribute to cisplatin resistance caused by TAMs in bladder cancer. Strategies to target GSTO1 could potentially improve the efficacy of cisplatin in treating bladder cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinDrug Resistance, NeoplasmExtracellular VesiclesGlutathione TransferaseTumor-Associated MacrophagesUrinary Bladder NeoplasmsHumansAntineoplastic AgentsCell Line, TumorMaleAnimalsMice

Stichwörter der Autor:innen

GSTO1bladder cancercisplatin resistanceextracellular vesicletumor‐associated macrophage

Substanzen

Antineoplastic AgentsCisplatinGlutathione TransferaseGSTO1 protein, human

Autor:innen und Institutionen

  • Ph.D. Program for Cancer Biology and Drug Discovery, China Medical University and Academia Sinica, Taichung, Taiwan.
  • Chinese Medicine Research and Development Center, China Medical University Hospital, Taichung, Taiwan.
  • Division of Hematology and Oncology, Department of Internal Medicine, China Medical University, Hospital, China Medical University, Taichung, Taiwan.
  • Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan.
  • Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.
  • Ph.D. Program in Translational Medicine, College of Medicine, Kaohsiung Medical University, Taiwan.

ORCID-Profile: Yi-Cheng Pan, Wei-Chao Chang, Yang-Chang Wu

Förderung

  • National Science and Technology Council, Taiwan
  • China Medical University
  • China Medical University Hospital
  • National Science and Technology Council

Zitieren

APA

Pan, Y. C., Chu, P. Y., Lin, C. C., Hsieh, C. Y., Hsu, W. Y., Shyur, L. F., Yang, J. C., Chang, W. C., & Wu, Y. C. (2024). Glutathione S ‐transferase omega class 1 ( GSTO1 )‐associated large extracellular vesicles are involved in tumor‐associated macrophage‐mediated cisplatin resistance in bladder cancer. Molecular Oncology. https://doi.org/10.1002/1878-0261.13659

Vancouver

Pan YC, Chu PY, Lin CC, Hsieh CY, Hsu WY, Shyur LF, et al. Glutathione S ‐transferase omega class 1 ( GSTO1 )‐associated large extracellular vesicles are involved in tumor‐associated macrophage‐mediated cisplatin resistance in bladder cancer. Molecular Oncology. 2024. doi:10.1002/1878-0261.13659

BibTeX
@article{Pan2024,
  author = {Pan, Yi-Cheng and Chu, Pei-Yi and Lin, Ching-Chan and Hsieh, Ching-Yun and Hsu, Wei-Yu and Shyur, Lie-Fen and Yang, Juan-Cheng and Chang, Wei-Chao and Wu, Yang-Chang},
  title = {Glutathione S ‐transferase omega class 1 ( GSTO1 )‐associated large extracellular vesicles are involved in tumor‐associated macrophage‐mediated cisplatin resistance in bladder cancer},
  journal = {Molecular Oncology},
  year = {2024},
  doi = {10.1002/1878-0261.13659}
}
Kostenlos starten →